191 related articles for article (PubMed ID: 2438053)
1. Modulation of carrier-induced epitopic suppression by Bordetella pertussis components and muramyl peptide.
Vogel FR; Leclerc C; Schutze MP; Jolivet M; Audibert F; Klein TW; Chedid L
Cell Immunol; 1987 Jun; 107(1):40-51. PubMed ID: 2438053
[TBL] [Abstract][Full Text] [Related]
2. Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine.
Podda A; Bona G; Canciani G; Pistilli AM; Contu B; Furlan R; Meloni T; Stramare D; Titone L; Rappuoli R
J Pediatr; 1995 Aug; 127(2):238-43. PubMed ID: 7636648
[TBL] [Abstract][Full Text] [Related]
3. Biologically active antibodies elicited by a synthetic circumsporozoite peptide of Plasmodium knowlesi administered in saline with a muramyl dipeptide derivative.
Clough ER; Audibert FM; Barnwell JW; Schlesinger DH; Arnon R; Chedid LA
Infect Immun; 1985 Jun; 48(3):839-42. PubMed ID: 3997250
[TBL] [Abstract][Full Text] [Related]
4. Enhanced epitopic response to a synthetic human malarial peptide by preimmunization with tetanus toxoid carrier.
Lise LD; Mazier D; Jolivet M; Audibert F; Chedid L; Schlesinger D
Infect Immun; 1987 Nov; 55(11):2658-61. PubMed ID: 2444539
[TBL] [Abstract][Full Text] [Related]
5. Epitopic suppression in synthetic vaccine models: analysis of the effector mechanisms.
Schutze MP; Leclerc C; Vogel FR; Chedid L
Cell Immunol; 1987 Jan; 104(1):79-90. PubMed ID: 2433056
[TBL] [Abstract][Full Text] [Related]
6. Effect of priming with carrier on response to conjugate vaccine.
Di John D; Wasserman SS; Torres JR; Cortesia MJ; Murillo J; Losonsky GA; Herrington DA; Stürcher D; Levine MM
Lancet; 1989 Dec; 2(8677):1415-8. PubMed ID: 2480499
[TBL] [Abstract][Full Text] [Related]
7. Neutralizing antibodies and immunoprotection against pertussis and tetanus obtained by use of a recombinant pertussis toxin-tetanus toxin fusion protein.
Boucher P; Sato H; Sato Y; Locht C
Infect Immun; 1994 Feb; 62(2):449-56. PubMed ID: 7507893
[TBL] [Abstract][Full Text] [Related]
8. Production of anti-sporozoite antibodies in absence of response to carrier by coupling an MDP derivative to a malaria peptide-tetanus toxoid conjugate.
Clough ER; Jolivet M; Audibert F; Barnwell JW; Schlesinger DH; Chedid L
Biochem Biophys Res Commun; 1985 Aug; 131(1):70-6. PubMed ID: 4038309
[TBL] [Abstract][Full Text] [Related]
9. Pertussis toxin enhanced IgG1 and IgE responses to primary tetanus immunization are mediated by interleukin-4 and persist during secondary responses to tetanus alone.
Samore MH; Siber GR
Vaccine; 1996 Mar; 14(4):290-7. PubMed ID: 8744555
[TBL] [Abstract][Full Text] [Related]
10. Protective immunogenicity of synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.
Askelöf P; Rodmalm K; Wrangsell G; Larsson U; Svenson SB; Cowell JL; Undén A; Bartfai T
Dev Biol Stand; 1991; 73():111-20. PubMed ID: 1778305
[TBL] [Abstract][Full Text] [Related]
11. Carrier-induced epitopic suppression is initiated through clonal dominance.
Schutze MP; Deriaud E; Przewlocki G; LeClerc C
J Immunol; 1989 Apr; 142(8):2635-40. PubMed ID: 2467933
[TBL] [Abstract][Full Text] [Related]
12. Cellular pertussis vaccine containing a Bordetella pertussis strain that produces a nontoxic pertussis toxin molecule.
Marsili I; Pizza M; Giovannoni F; Volpini G; Bartalini M; Olivieri R; Rappuoli R; Nencioni L
Infect Immun; 1992 Mar; 60(3):1150-5. PubMed ID: 1541530
[TBL] [Abstract][Full Text] [Related]
13. Epitope-specific regulation. I. Carrier-specific induction of suppression for IgG anti-hapten antibody responses.
Herzenberg LA; Tokuhisa T
J Exp Med; 1982 Jun; 155(6):1730-40. PubMed ID: 6176665
[TBL] [Abstract][Full Text] [Related]
14. [The immunological basis of the administration of DTP-polio vaccine].
Cohen H
Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
[TBL] [Abstract][Full Text] [Related]
15. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children.
Pichichero ME; Deloria MA; Rennels MB; Anderson EL; Edwards KM; Decker MD; Englund JA; Steinhoff MC; Deforest A; Meade BD
Pediatrics; 1997 Nov; 100(5):772-88. PubMed ID: 9346976
[TBL] [Abstract][Full Text] [Related]
16. Epitope of the vaccine-type Bordetella pertussis strain 186 lipooligosaccharide and antiendotoxin activity of antibodies directed against the terminal pentasaccharide-tetanus toxoid conjugate.
Niedziela T; Letowska I; Lukasiewicz J; Kaszowska M; Czarnecka A; Kenne L; Lugowski C
Infect Immun; 2005 Nov; 73(11):7381-9. PubMed ID: 16239537
[TBL] [Abstract][Full Text] [Related]
17. Comparisons of the effect of naturally acquired maternal pertussis antibodies and antenatal vaccination induced maternal tetanus antibodies on infant's antibody secreting lymphocyte responses and circulating plasma antibody levels.
Ahmad SM; Alam J; Afsar NA; Huda N; Kabir Y; Qadri F; Raqib R; Stephensen CB
Hum Vaccin Immunother; 2016 Apr; 12(4):886-93. PubMed ID: 27176823
[TBL] [Abstract][Full Text] [Related]
18. Role of muramyl peptides for the enhancement of synthetic vaccines.
Chedid L; Audibert F; Jolivet M
Dev Biol Stand; 1986; 63():133-40. PubMed ID: 3527818
[TBL] [Abstract][Full Text] [Related]
19. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model.
Kwon HJ; Han SB; Kim BR; Kang KR; Huh DH; Choi GS; Ahn DH; Kang JH
BMC Infect Dis; 2017 Apr; 17(1):247. PubMed ID: 28376777
[TBL] [Abstract][Full Text] [Related]
20. Induction of CD4(+) and CD8(+) Bordetella pertussis toxin subunit S1 specific T cells by immunization with synthetic peptides.
Fagerberg J; Askelöf P; Wigzell H; Mellstedt H
Cell Immunol; 1999 Sep; 196(2):110-21. PubMed ID: 10527563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
